• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Comparison of COVID-19 testing strategies and costs for professional sports teams: A case study of J. League clubs

tetano

Editor, Senior Moderator
PLoS One


. 2025 Apr 7;20(4):e0310939.
doi: 10.1371/journal.pone.0310939. eCollection 2025. Comparison of COVID-19 testing strategies and costs for professional sports teams: A case study of J. League clubs

Masashi Kamo[SUP] 1 [/SUP], Michio Murakami[SUP] 2 [/SUP], Wataru Naito[SUP] 1 [/SUP], Tetsuo Yasutaka[SUP] 3 [/SUP], Seiya Imoto[SUP] 4 [/SUP]



Affiliations
Abstract

Professional sports teams are entertainment groups that earn income through performances, and they recognize that efforts to prevent the within-team spread of infection that could lead to performance cancellation are important. Infectious disease control involves several costs, some of which are in a trade-off relationship. For example, frequent testing can reduce the spread of infection, but it also leads to increased costs. On the other hand, limiting the number of tests can reduce testing costs, but it increases the revenue loss from players becoming infected and the loss from canceling games. Therefore, a methodology that strikes a reasonable balance between the cost of control measures and the risk of infection is needed. The relationship between infection control measures and the number of infected individuals was investigated through simulations using the susceptible-exposed-infected-recovered (SEIR) model. Two types of testing scenarios as control measures were principally considered: rapid antigen testing or the slower PCR testing (regular-testing scenarios); and regular testing with more frequent, additional testing after the appearance of an infected individual (additional-testing scenarios). Testing fees, revenue loss due to player or staff inactivity as a result of infection, and expenses for postponement or cancelation of matches were considered as costs. Regular antigen testing was found to be more effective than PCR testing in reducing the number of infected individuals and associated costs. There are two main reasons why antigen testing was more efficient: It is less expensive than PCR testing; and the results are available sooner (immediately, versus at least a day of waiting time for the PCR results). This was shown to markedly reduce the number of infected individuals.


 
Back
Top Bottom